secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0000937556-24-000106
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo Q3 healthcare revenue up 11.7% CC; raises FY non-GAAP EPS guidance to $3.95-$4.10
--------------------------------------------------------------------------------

- Healthcare revenue $343.3M (+11.7% CC); total revenue $504.6M; 60,500 board/instrument shipments.
- GAAP EPS $0.18; Non-GAAP EPS $0.98; GAAP operating income $30.1M, non-GAAP $80.8M.
- Raised FY2024 non-GAAP EPS guidance to $3.95-$4.10 from prior $3.80-$4.00; operating income $325-$336M.
- Narrowed FY total revenue guidance to $2.075-$2.105B from $2.085-$2.135B; healthcare $1.390-$1.400B.
- Interim CEO cites ongoing portfolio review, R&D focus on sizable markets, and strategic review of consumer business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000106/0000937556-24-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000106/masi-20241105.htm
  HTML page:      https://secwatch.observer/filing/0000937556-24-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer